NASDAQ:TRNS

Transcat Stock Forecast, Price & News

$61.75
-0.30 (-0.48 %)
(As of 09/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$61.59
$63.41
50-Day Range
$58.32
$68.09
52-Week Range
$26.05
$68.40
Volume22,005 shs
Average Volume35,662 shs
Market Capitalization$461.27 million
P/E Ratio43.79
Dividend YieldN/A
Beta0.72
30 days | 90 days | 365 days | Advanced Chart
Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Transcat and its competitors with MarketBeat's FREE daily newsletter.


Transcat logo

About Transcat

Transcat, Inc. engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.18 out of 5 stars

Computer And Technology Sector

312th out of 858 stocks

Instruments To Measure Electricity Industry

5th out of 9 stocks

Analyst Opinion: 1.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Transcat (NASDAQ:TRNS) Frequently Asked Questions

Is Transcat a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Transcat stock.
View analyst ratings for Transcat
or view top-rated stocks.

What stocks does MarketBeat like better than Transcat?

Wall Street analysts have given Transcat a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Transcat wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Transcat's next earnings date?

Transcat is scheduled to release its next quarterly earnings announcement on Tuesday, October 26th 2021.
View our earnings forecast for Transcat
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) released its quarterly earnings results on Tuesday, July, 27th. The scientific and technical instruments company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.23. The scientific and technical instruments company had revenue of $47.79 million for the quarter, compared to analysts' expectations of $44.30 million. Transcat had a trailing twelve-month return on equity of 14.51% and a net margin of 5.86%.
View Transcat's earnings history
.

How has Transcat's stock been impacted by COVID-19 (Coronavirus)?

Transcat's stock was trading at $27.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRNS shares have increased by 121.9% and is now trading at $61.75.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TRNS?

6 brokers have issued 1 year target prices for Transcat's shares. Their forecasts range from $43.50 to $73.00. On average, they anticipate Transcat's share price to reach $63.25 in the next twelve months. This suggests a possible upside of 2.4% from the stock's current price.
View analysts' price targets for Transcat
or view top-rated stocks among Wall Street analysts.

Who are Transcat's key executives?

Transcat's management team includes the following people:
  • Lee D. Rudow, President, Chief Executive Officer & Director
  • Leanne E. Branham, Vice President-Operations
  • Mark A. Doheny, Chief Financial Officer & Vice President-Finance
  • Andrew J. Quaranto, Vice President-Information Technology
  • Michael W. West, Vice President-Marketing & Distribution

What is Lee Rudow's approval rating as Transcat's CEO?

20 employees have rated Transcat CEO Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among Transcat's employees.

Who are some of Transcat's key competitors?

What other stocks do shareholders of Transcat own?

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Who are Transcat's major shareholders?

Transcat's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Neuberger Berman Group LLC (10.55%), Wasatch Advisors Inc. (10.13%), BlackRock Inc. (5.71%), Vanguard Group Inc. (5.55%), Punch & Associates Investment Management Inc. (4.02%) and Champlain Investment Partners LLC (3.16%). Company insiders that own Transcat stock include Carl E Sassano, Charles P Hadeed, Craig D Cairns, Gary J Haseley, Lee D Rudow, Michael Tschiderer, Michael W West and Scott Deverell.
View institutional ownership trends for Transcat
.

Which major investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Ancora Advisors LLC, Minerva Advisors LLC, Russell Investments Group Ltd., JPMorgan Chase & Co., Anchor Capital Advisors LLC, Royal Bank of Canada, and Bank of America Corp DE. Company insiders that have sold Transcat company stock in the last year include Charles P Hadeed, Lee D Rudow, Michael W West, and Scott Deverell.
View insider buying and selling activity for Transcat
or view top insider-selling stocks.

Which major investors are buying Transcat stock?

TRNS stock was acquired by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Punch & Associates Investment Management Inc., Champlain Investment Partners LLC, Vanguard Group Inc., Morgan Stanley, Morgan Stanley, Goldman Sachs Group Inc., and Marshall Wace LLP. Company insiders that have bought Transcat stock in the last two years include Craig D Cairns, Gary J Haseley, and Michael Tschiderer.
View insider buying and selling activity for Transcat
or or view top insider-buying stocks.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $61.75.

How much money does Transcat make?

Transcat has a market capitalization of $461.27 million and generates $173.34 million in revenue each year. The scientific and technical instruments company earns $7.79 million in net income (profit) each year or $1.03 on an earnings per share basis.

How many employees does Transcat have?

Transcat employs 765 workers across the globe.

What is Transcat's official website?

The official website for Transcat is www.transcat.com.

Where are Transcat's headquarters?

Transcat is headquartered at 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at (585) 352-7777 or via email at [email protected].


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.